Pyronaridine

Pyronaridine
Clinical data

Routes of administration	Oral, intramuscular injection, intravenous therapy
ATC code	none
Legal status
Legal status	CLP (EU): Acute Tox. 3(H301), Eye Dam. 1 (H318), Repr. 2 (H361), Aquatic Chronic 4 (H413)
Identifiers
IUPAC name 4-[(7-Chloro-2-methoxy-pyrido[3,2-b]quinolin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol
CAS Number	74847-35-1^N
PubChem CID	5485198
ChemSpider	10647812^Y
UNII	TD3P7Q3SG6
ChEMBL	CHEMBL35228^Y
Chemical and physical data
Formula	C₂₉H₃₂ClN₅O₂
Molar mass	518.05 g/mol
3D model (Jmol)	Interactive image
SMILES Clc1ccc6c(c1)nc2ccc(OC)nc2c6Nc5cc(CN3CCCC3)c(O)c(CN4CCCC4)c5
InChI InChI=1S/C29H32ClN5O2/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35/h6-9,14-16,36H,2-5,10-13,17-18H2,1H3,(H,31,32)^Y Key:DJUFPMUQJKWIJB-UHFFFAOYSA-N^Y
^NY (what is this?)

Pyronaridine is an antimalarial drug. It was first synthesized in 1970 and has been in clinical use in China since the 1980s.

It is one of the components of the artemisinin combination therapy pyronaridine artesunate (Pyramax).